US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 21st August 2019 with two (2) minor observations. This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.91.25 as compared to the previous close of Rs. 93.35. The total number of shares traded during the day was 36934 in over 552 trades.
The stock hit an intraday high of Rs. 94 and intraday low of 90.35. The net turnover during the day was Rs. 3409272.